Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy

Targeted axillary dissection reduces residual nodal disease in clinically node- positive breast cancer after neoadjuvant chemotherapy

Abstract Background Any advantage of performing targeted axillary dissection (TAD) compared to sentinel lymph node (SLN) biopsy (SLNB) is under debate in clinically node-positive (cN+) patients diagnosed with breast cancer. Our objective was to assess the feasibility of the removal of the clipped n...

Full description

Bibliographic Details
Main Authors: Neslihan Cabıoğlu, Hasan Karanlık, Ravza Yılmaz, Selman Emiroğlu, Mustafa Tükenmez, Süleyman Bademler, Duygu Has Şimşek, Tarık Recep Kantarcı, İnci Kızıldağ Yirgin, Aysel Bayram, Memduh Dursun
Format: Article
Language:English
Published: BMC 2024-07-01
Series:World Journal of Surgical Oncology
Subjects:
Sentinel lymph node biopsy
Neoadjuvant chemotherapy
Targeted axillary dissection
Clipped node
Wire-localisation
Radio-guided occult lesion localisation (ROLL)
Online Access:https://doi.org/10.1186/s12957-024-03413-6

Internet

https://doi.org/10.1186/s12957-024-03413-6

Similar Items